Miniatura

Fitxers

genes-12-00150-v4.pdf (362.16 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-01-23

Llicència de publicació

cc by (c) Rofes et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/175003

BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3390/genes12020150

Resum

Only a small fraction of hereditary breast and/or ovarian cancer (HBOC) cases are caused by germline variants in the high-penetrance breast cancer 1 and 2 genes (BRCA1 and BRCA2). BRCA1-associated ring domain 1 (BARD1), nuclear partner of BRCA1, has been suggested as a potential HBOC risk gene, although its prevalence and penetrance are variable according to populations and type of tumor. We aimed to investigate the prevalence of BARD1 truncating variants in a cohort of patients with clinical suspicion of HBOC. A comprehensive BARD1 screening by multigene panel analysis was performed in 4015 unrelated patients according to our regional guidelines for genetic testing in hereditary cancer. In addition, 51,202 Genome Aggregation Database (gnomAD) non-Finnish, non-cancer European individuals were used as a control population. In our patient cohort, we identified 19 patients with heterozygous BARD1 truncating variants (0.47%), whereas the frequency observed in the gnomAD controls was 0.12%. We found a statistically significant association of truncating BARD1 variants with overall risk (odds ratio (OR) = 3.78; CI = 2.10-6.48; p = 1.16 x 10(-5)). This association remained significant in the hereditary breast cancer (HBC) group (OR = 4.18; CI = 2.10-7.70; p = 5.45 x 10(-5)). Furthermore, deleterious BARD1 variants were enriched among triple-negative BC patients (OR = 5.40; CI = 1.77-18.15; p = 0.001) compared to other BC subtypes. Our results support the role of BARD1 as a moderate penetrance BC predisposing gene and highlight a stronger association with triple-negative tumors.

Matèries

Càncer de mama, Càncer d'ovari

Matèries (anglès)

Breast cancer, Ovarian cancer

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

ROFES, Paula, VALLE, Jesús del, TORRES ESQUIUS, Sara, FELIUBADALÓ I ELORZA, Maria lídia, STRADELLA, Agostina, MORENO CABRERA, José marcos, LÓPEZ DÓRIGA GUERRA, Adriana, MUNTÉ, Elisabet, CID, Rafael de, CAMPOS, Olga, CUESTA, Raquel, TEULÉ-VEGA, Àlex, GRAU GARCÉS, Èlia, SANZ, Judit, CAPELLÁ, G. (gabriel), DÍEZ GIBERT, Orland, BRUNET, Joan, BALMAÑA, Judith, LÁZARO GARCÍA, Conxi. BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort. _Genes_. 2021. Vol. 12, núm. 2. [consulta: 22 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/175003]

Exportar metadades

JSON - METS

Compartir registre